BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced that the Company’s management will host a conference call and webcast on Wednesday, November 1 2023 at 8:00 AM Eastern Time. BioVie’s President and CEO Cuong Do, Chief Medical Officer Dr. Joseph Palumbo, and Dr. Steven Arnold of the Harvard Medical School will review recent data on NE3017 presented at the 16th Clinical Trials on Alzheimer’s Disease (CTAD) conference.
Registration details are as follows:
| Date | November 1, 2023 |
| Time | 8:00 AM Eastern Time |
| Conference Call Details | 1-877-407-3982 (U.S. Investors Dial-in) 1-201-493-6780 (International Investors Dial-in) 13742478 (Conference ID Code) |
| Webcast Link | Click Here |
| Call-ME™ Feature | Click Here |
| https://www.globenewswire.com/news-release/2023/10/30/2769132/0/en/BioVie-to-Host-Conference-Call-and-Webcast-Wednesday-November-1-2023-at-8-00-AM-ET.html |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.